HAYA Therapeutics
Developer of RNA-based therapies for treating heart diseases. It offers a platform that integrates multimodal functional genomics with computational tools to determine RNA-targeting modalities, such as modified antisense oligonucleotides (ASOs) to inhibit lncRNAs to prevent Fibrosis. Founded in 2017, headquartered in Lausanne, Switzerland. The company has raised $90.0M in funding at the series a stage. The team…
Funding snapshot
About
Developer of RNA-based therapies for treating heart diseases. It offers a platform that integrates multimodal functional genomics with computational tools to determine RNA-targeting modalities, such as modified antisense oligonucleotides (ASOs) to inhibit lncRNAs to prevent Fibrosis. Founded in 2017, headquartered in Lausanne, Switzerland. The company has raised $90.0M in funding at the series a stage. The team comprises 68 (Jun 30, 2026) employees. HAYA Therapeutics operates in the Genomics, Cardiac and Vascular Disorders, Gene Therapy, Clinical Genomics sectors. The company focuses on Diversified, Non-Coding RNA, MassCha. Notable investors include Broadview Ventures, Apollo Health Ventures, 4see ventures, Schroders Capital, Viva BioInnovator, BERNINA BioInvest, among others. The company has a team of 68 employees.
Business model
Cardiac and Vascular Disorders > Drugs > Diversified,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Genetic Diagnosis > Transcriptomics > Non-Coding RNA,
MassChallenge Batches > Switzerland > 2017 > Gold
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.